Plus Therapeutics (PSTV) Current Deferred Revenue (2010 - 2026)
Plus Therapeutics (PSTV) reported Current Deferred Revenue of $927000.0 for Q1 2026, down 28.53% year-over-year from $1.3 million in Q1 2025, and little changed quarter-over-quarter from $927000.0 in Q4 2025.
Plus Therapeutics (PSTV) Current Deferred Revenue (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 13 years of Current Deferred Revenue data on file, last reported at $927000.0 in Q1 2026.
- Current Deferred Revenue for Q1 2026 came in at $927000.0, down 28.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $927000.0 (down 28.53% YoY), and the FY2025 annual result was $927000.0, changed 0.0% from the prior year.
- Current Deferred Revenue held at $927000.0 in Q1 2026 per PSTV's latest filing, from $927000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $2.3 million in Q2 2024 and troughed at $247000.0 in Q1 2024.
- A 4-year average of $1.1 million and a median of $927000.0 in 2024 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2024 and 2025: Current Deferred Revenue tumbled 78.28% in 2024, then jumped 425.1% in 2025.
- A 4-year view of Current Deferred Revenue shows it stood at $1.1 million in 2023, then slipped by 18.47% to $927000.0 in 2024, then changed by 0.0% to $927000.0 in 2025, then changed by 0.0% to $927000.0 in 2026.
- Business Quant data shows PSTV's Current Deferred Revenue at $927000.0 in Q1 2026, $927000.0 in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 927,000.00 |
| Dec 31, 2025 | 927,000.00 |
| Sep 30, 2025 | 1.97 Mn |
| Jun 30, 2025 | 927,000.00 |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 927,000.00 |
| Sep 30, 2024 | 840,000.00 |
| Jun 30, 2024 | 2.30 Mn |
| Mar 31, 2024 | 247,000.00 |
| Mar 31, 2023 | 1.14 Mn |
| Jun 30, 2018 | 217,000.00 |
| Mar 31, 2018 | 178,000.00 |
| Dec 31, 2017 | 94,000.00 |
| Sep 30, 2017 | 103,000.00 |
| Jun 30, 2017 | 110,000.00 |
| Mar 31, 2017 | 109,000.00 |
| Dec 31, 2016 | 97,000.00 |
| Sep 30, 2016 | 97,000.00 |
| Jun 30, 2016 | 106,000.00 |
| Mar 31, 2016 | 101,000.00 |